FDA Approves Clarinex-D 12 Hour

Feb. 3, 2007 — A newer turning of the medication allergy music Clarinex has been approved by the FDA to dainty nasal bone and non-nasal symptoms of seasonal allergies including bone over-crowding in adults and children over age 12.
Researchers say the new Clarinex-D 12 Hour should be available in time for the fountain allergy period.
Clarinex (desloratadine) is a nonsedating antihistamine available by written communication for the intervention of seasonal allergy symptoms.
Clarinex-D 24 Hour (containing 5 milligrams desloratadine and 240 milligrams pseudoephedrine) as a once-daily black and white was approved last jumping.
The newly approved Claritin-D 12 Hour contains 2.5 milligrams desloratadine and 120 milligrams pseudoephedrine.
The recommended dosing would be twice a day.
The FDA based its favourable reception on two clinical trials involving more than 1,200 the great unwashed with seasonal allergies.
The studies compared discourse of Clarinex-D 12 HOUR extended-release tablets with pseudoephedrine alone and desloratadine alone.
The results showed that the extended-release-combined medicament effectively relieved bone symptom as well as provided significantly greater suspension than desloratadine alone and that it relieved other allergy symptoms (excluding consonant congestion) good than pseudoephedrine alone.
The most common side effects associated with Clarinex-D 12 Hour were insomnia, aching, dry orifice, and assignment.
It should not be taken by those with narrow-angle glaucoma, severe high descent pressing or viscus disease, urination trouble, or by patients who may have taken a monoamine-oxidase inhibitor within the past 14 days.
Those with certain other medical healthiness such as high lineage pressure sensation, diabetes, bravery disease, thyroid, soul, or kidney problems, or enlarged prostate should bill with their condition care supplier prior to using Clarinex-D 12 hour or Clarinex-D 24 Hour.
About 36 trillion family in the U.S. are affected by seasonal allergies.
Symptoms include runny nose, sneezing, nasal bone over-crowding, and itchy, watery eyes. NATURAL ACTION: FDA.
News sack, Schering-Plough Corp.
This is a part of article FDA Approves Clarinex-D 12 Hour Taken from "Generic Clarinex (Desloratadine) Page" Information Blog